Affordable and Safe Prescription Drug Importation Act
Latest action · Mar 23, 2021 Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held. With printed Hearing: S.Hrg. 117-176.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 23, 2021
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Affordable and Safe Prescription Drug Importation Act
This bill allows expanded importation of eligible prescription drugs and addresses related issues.
Current law allows the Department of Health and Human Services (HHS) to authorize the importation of certain eligible prescription drugs from Canada if HHS certifies to Congress that doing so would pose no additional risk to public health and safety and would result in significant cost savings for consumers. The bill removes this certification requirement and requires HHS to issue regulations that permit the importation of qualifying prescription drugs from Canada. After a certain amount of time, HHS may authorize importation from certain other countries if it determines that importation from Canada has resulted in cost savings for consumers and increased access to safe medication.
The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin.
Furthermore, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS.
The bill imposes various requirements related to certification of foreign sellers, labeling of imported drugs, and supply chain security.
The bill also (1) prohibits certain acts that discriminate against foreign sellers, such as charging higher prices to foreign sellers than to other sellers in the same country; and (2) imposes criminal penalties for online websites that sell counterfeit drugs or dispense drugs without a required prescription.
Cosponsors 21
Members who signed on, in the order they did. All signed on Mar 23, 2021.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Alex Padilla | Original | Mar 23, 2021 |
| D-MN | Amy Klobuchar | Original | Mar 23, 2021 |
| I-ME | Angus S. King Jr. | Original | Mar 23, 2021 |
| D-MD | Chris Van Hollen | Original | Mar 23, 2021 |
| D-NJ | Cory A. Booker | Original | Mar 23, 2021 |
| D-MI | Debbie Stabenow | Original | Mar 23, 2021 |
| D-MA | Elizabeth Warren | Original | Mar 23, 2021 |
| D-RI | Jack Reed | Original | Mar 23, 2021 |
| D-NH | Jeanne Shaheen | Original | Mar 23, 2021 |
| D-OR | Jeff Merkley | Original | Mar 23, 2021 |
| D-WV | Joe Manchin III | Original | Mar 23, 2021 |
| D-NY | Kirsten E. Gillibrand | Original | Mar 23, 2021 |
| D-NM | Martin Heinrich | Original | Mar 23, 2021 |
| D-VT | Patrick J. Leahy | Original | Mar 23, 2021 |
| D-CT | Richard Blumenthal | Original | Mar 23, 2021 |
| D-PA | Robert P. Casey Jr. | Original | Mar 23, 2021 |
| D-OR | Ron Wyden | Original | Mar 23, 2021 |
| D-RI | Sheldon Whitehouse | Original | Mar 23, 2021 |
| D-OH | Sherrod Brown | Original | Mar 23, 2021 |
| D-WI | Tammy Baldwin | Original | Mar 23, 2021 |
| D-MN | Tina Smith | Original | Mar 23, 2021 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Mar 23, 2021 |
| Primary Health and Retirement Security Subcommittee | Hearings Mar 23, 2021 |
Actions 3
Everything that happened, newest first.
- Mar 23, 2021Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held. With printed Hearing: S.Hrg. 117-176.
- Mar 23, 2021Introduced in Senate
- Mar 23, 2021Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R44832 | Frequently Asked Questions About Prescription Drug Pricing and Policy | Report | May 6, 2021 |
Related bills 3
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 97 | Affordable and Safe Prescription Drug Importation Act | Reintroduction of | Jan 10, 2019 |
| S 1898 | Affordable Medications Act | Related bill | May 27, 2021 |
| HR 2181 | Affordable and Safe Prescription Drug Importation Act | Identical bill | Mar 24, 2021 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
- Short Title(s) as Introduced
- Affordable and Safe Prescription Drug Importation Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Canada
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Government information and archives
- Government studies and investigations
- Health
- Prescription drugs
- Trade restrictions
- User charges and fees
Text 1
Each version as it was printed, newest first.
- Mar 23, 2021Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.